These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 18703118)

  • 1. Abnormal expression of synaptic proteins and neurotrophin-3 in the Down syndrome mouse model Ts65Dn.
    Pollonini G; Gao V; Rabe A; Palminiello S; Albertini G; Alberini CM
    Neuroscience; 2008 Sep; 156(1):99-106. PubMed ID: 18703118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normalization of Dyrk1A expression by AAV2/1-shDyrk1A attenuates hippocampal-dependent defects in the Ts65Dn mouse model of Down syndrome.
    Altafaj X; Martín ED; Ortiz-Abalia J; Valderrama A; Lao-Peregrín C; Dierssen M; Fillat C
    Neurobiol Dis; 2013 Apr; 52():117-27. PubMed ID: 23220201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rescue of synaptic failure and alleviation of learning and memory impairments in a trisomic mouse model of down syndrome.
    Blanchard J; Bolognin S; Chohan MO; Rabe A; Iqbal K; Grundke-Iqbal I
    J Neuropathol Exp Neurol; 2011 Dec; 70(12):1070-9. PubMed ID: 22082658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal protein composition of synapses in Ts65Dn mice: a mouse model of Down syndrome.
    Fernandez F; Trinidad JC; Blank M; Feng DD; Burlingame AL; Garner CC
    J Neurochem; 2009 Jul; 110(1):157-69. PubMed ID: 19453946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroanatomical alterations and synaptic plasticity impairment in the perirhinal cortex of the Ts65Dn mouse model of Down syndrome.
    Roncacé V; Burattini C; Stagni F; Guidi S; Giacomini A; Emili M; Aicardi G; Bartesaghi R
    Neurobiol Dis; 2017 Oct; 106():89-100. PubMed ID: 28651891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synaptic and cognitive abnormalities in mouse models of Down syndrome: exploring genotype-phenotype relationships.
    Belichenko PV; Kleschevnikov AM; Salehi A; Epstein CJ; Mobley WC
    J Comp Neurol; 2007 Oct; 504(4):329-45. PubMed ID: 17663443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that increased Kcnj6 gene dose is necessary for deficits in behavior and dentate gyrus synaptic plasticity in the Ts65Dn mouse model of Down syndrome.
    Kleschevnikov AM; Yu J; Kim J; Lysenko LV; Zeng Z; Yu YE; Mobley WC
    Neurobiol Dis; 2017 Jul; 103():1-10. PubMed ID: 28342823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lithium rescues synaptic plasticity and memory in Down syndrome mice.
    Contestabile A; Greco B; Ghezzi D; Tucci V; Benfenati F; Gasparini L
    J Clin Invest; 2013 Jan; 123(1):348-61. PubMed ID: 23202733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal expression of the G-protein-activated inwardly rectifying potassium channel 2 (GIRK2) in hippocampus, frontal cortex, and substantia nigra of Ts65Dn mouse: a model of Down syndrome.
    Harashima C; Jacobowitz DM; Witta J; Borke RC; Best TK; Siarey RJ; Galdzicki Z
    J Comp Neurol; 2006 Feb; 494(5):815-33. PubMed ID: 16374808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lifespan analysis of brain development, gene expression and behavioral phenotypes in the Ts1Cje, Ts65Dn and Dp(16)1/Yey mouse models of Down syndrome.
    Aziz NM; Guedj F; Pennings JLA; Olmos-Serrano JL; Siegel A; Haydar TF; Bianchi DW
    Dis Model Mech; 2018 Jun; 11(6):. PubMed ID: 29716957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphological alterations in the hippocampus of the Ts65Dn mouse model for Down Syndrome correlate with structural plasticity markers.
    Villarroya O; Ballestín R; López-Hidalgo R; Mulet M; Blasco-Ibáñez JM; Crespo C; Nacher J; Gilabert-Juan J; Varea E
    Histol Histopathol; 2018 Jan; 33(1):101-115. PubMed ID: 28374408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome.
    Stagni F; Giacomini A; Emili M; Trazzi S; Guidi S; Sassi M; Ciani E; Rimondini R; Bartesaghi R
    Neuroscience; 2016 Oct; 333():277-301. PubMed ID: 27457036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A flavonoid agonist of the TrkB receptor for BDNF improves hippocampal neurogenesis and hippocampus-dependent memory in the Ts65Dn mouse model of DS.
    Stagni F; Giacomini A; Guidi S; Emili M; Uguagliati B; Salvalai ME; Bortolotto V; Grilli M; Rimondini R; Bartesaghi R
    Exp Neurol; 2017 Dec; 298(Pt A):79-96. PubMed ID: 28882412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered synaptic marker abundance in the hippocampal stratum oriens of Ts65Dn mice is associated with exuberant expression of versican.
    Howell MD; Gottschall PE
    ASN Neuro; 2012 Feb; 4(1):. PubMed ID: 22225533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The "Down syndrome critical region" is sufficient in the mouse model to confer behavioral, neurophysiological, and synaptic phenotypes characteristic of Down syndrome.
    Belichenko NP; Belichenko PV; Kleschevnikov AM; Salehi A; Reeves RH; Mobley WC
    J Neurosci; 2009 May; 29(18):5938-48. PubMed ID: 19420260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the cause of mental retardation in Down syndrome: extrapolation from full and segmental trisomy 16 mouse models.
    Galdzicki Z; Siarey R; Pearce R; Stoll J; Rapoport SI
    Brain Res Brain Res Rev; 2001 Apr; 35(2):115-45. PubMed ID: 11336779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excitatory-inhibitory relationship in the fascia dentata in the Ts65Dn mouse model of Down syndrome.
    Belichenko PV; Kleschevnikov AM; Masliah E; Wu C; Takimoto-Kimura R; Salehi A; Mobley WC
    J Comp Neurol; 2009 Feb; 512(4):453-66. PubMed ID: 19034952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired plasticity at specific subset of striatal synapses in the Ts65Dn mouse model of Down syndrome.
    Di Filippo M; Tozzi A; Ghiglieri V; Picconi B; Costa C; Cipriani S; Tantucci M; Belcastro V; Calabresi P
    Biol Psychiatry; 2010 Apr; 67(7):666-71. PubMed ID: 19818432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early appearance of developmental alterations in the dendritic tree of the hippocampal granule cells in the Ts65Dn model of Down syndrome.
    Uguagliati B; Al-Absi AR; Stagni F; Emili M; Giacomini A; Guidi S; Nyengaard JR; Bartesaghi R
    Hippocampus; 2021 Apr; 31(4):435-447. PubMed ID: 33464704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formoterol, a long-acting β2 adrenergic agonist, improves cognitive function and promotes dendritic complexity in a mouse model of Down syndrome.
    Dang V; Medina B; Das D; Moghadam S; Martin KJ; Lin B; Naik P; Patel D; Nosheny R; Wesson Ashford J; Salehi A
    Biol Psychiatry; 2014 Feb; 75(3):179-88. PubMed ID: 23827853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.